Nexus Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Nexus Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54.9K	Hold	953	–	–	0.01%	55
2026 Q1	$57.8K	Hold	953	–	–	0.01%	57
2025 Q4	$51.4K	Hold	953	–	–	0.01%	59
2025 Q3	$43K	Hold	953	–	–	0.01%	60
2025 Q2	$44.1K	Hold	953	–	–	0.01%	62
2025 Q1	$83.6K	Buy	+953	New	+$55.5K	0.01%	57
2023 Q2	–	Sell	-2,953	Closed	-$205K	–	73
2023 Q1	$205K	Hold	2,953	–	–	0.02%	72
2022 Q4	$212K	Buy	+2,953	New	+$223K	0.02%	71

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Nexus Investment Management's BMY Position: Q2 2026 in Review

Nexus Investment Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 953 shares worth $54.9K. The position accounts for 0.01% of the portfolio, ranked #55.

Nexus Investment Management first reported a position in BMY in Q4 2022 and has held it in 8 quarters since. The position peaked at $212K in Q4 2022. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Nexus Investment Management held 953 shares of Bristol-Myers Squibb worth $54.9K as of Q2 2026.
Nexus Investment Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.01% of Nexus Investment Management's portfolio in Q2 2026, its #55 holding.
Nexus Investment Management first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 8 quarters since.
Nexus Investment Management's Bristol-Myers Squibb position peaked at $212K in Q4 2022.
796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Nexus Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.